Granuloma formation, the principal pathologic consequence of infection with Schistosoma mansoni, is a complex process involving intricate cell-cell interactions in which intercellular adhesion molecules are likely to participate. To examine this possibility, sera of schistosomiasis patients in various clinical groups were assayed for the presence of soluble intercellular adhesion molecule 1 (sICAM-1) and soluble E-selectin (sE-selectin).
The pathology associated with Schistosoma mansoni infections results from parasite eggs lodging in the presinusoidal capillaries of the liver where they stimulate granuloma formation. Granulomas are highly organized cellular lesions orchestrated by T cells responding to egg antigens (19, 34, 38) . Although T cells control this event, several cell types interacting with each other as well as with the extracellular matrix are important for overall granuloma architecture. Integrins, selectins, and cytokines are important for cell-cell communication among both hematopoietic and nonhematopoietic cell types and thereby provide a variety of mechanisms by which these cells can influence one another (48, 49) . The effect of cytokines in schistosomal infections continues to be an area of intense research; however, investigation of the role of cellular adhesion molecules in this disease has begun only recently (42) .
One of these adhesion molecules, intercellular adhesion molecule 1 (ICAM-1; CD54), is a cell surface glycoprotein belonging to the immunoglobulin superfamily of proteins (48) (49) (50) . It is present on endothelial cells, antigen-presenting cells, and fibroblasts (16, 48, 49) . Typically, it is expressed at low levels on these cells, but increased expression can be induced by interleukin-1, gamma interferon (IFN-y), or tumor necrosis factor alpha (TNF-a) (16, 17, 49) . ICAM-1 performs several vital roles in the normal functioning of the immune system. For example, lymphocytes and other leukocytes inter-act with ICAM-1 on vascular endothelial cells during recruitment into tissues undergoing inflammatory responses (9, 10, 17, 21, 29, 48, 52) . Also, T-cell interactions with ICAM-1 on antigen-presenting cells stabilize the cell-cell interaction and reduce the threshold for antigen-specific activation (15, 20, 28, 35, 44, 55) . Thus, ICAM-1 performs an important function in directing cells to sites of inflammation as well as activating them once they arrive.
Another important participant in diapedesis is endothelial leukocyte adhesion molecule 1 (E-selectin; ELAM-1). This molecule is a member of the selectin family of intercellular adhesion molecules and participates in the initial attachment of leukocytes to vascular endothelium during cellular emigration (5, 30, 48) . E-selectin is not expressed on resting endothelial cells but, like ICAM-1, can be induced by interleukin-1, TNF-a, or lipopolysaccharide (6, 7, 30) . E-selectin is described primarily as a receptor for neutrophil transendothelial migration, but it can also serve as a receptor for eosinophils (29, 56) , monocytes (11, 25) , natural killer cells (31) , and CD4+ memory T cells (24, 31, 39, 47) . The tissue location of and specific cytokine stimulus to the vascular endothelium determine which leukocyte population(s) adheres (37, 46) .
Recently, soluble forms of ICAM-1 and E-selectin have been described. The structure of soluble ICAM-1 (sICAM-1) is consistent with a membrane-cleaved variant of cellular ICAM-1 and maintains its ligand-binding ability (40, 43) . The physiologic function of sICAM-1 is unknown, but interestingly, its release from cells is effected by some of the same cytokines which cause upregulation of cell surface expression (2, 40 (42) . In addition, some cytokines which are involved in granuloma formation (e.g., interleukin-1, TNF-o, and IFN--y) (1, 13, 14, 26) are also associated with increased levels of cell surface and soluble adhesion molecules (2, 6, 7, 16, 17, 30, 40, 49) . To . Serum sICAM-1 levels in all groups were significantly different (P < 0.001 for each) from that of the normal control group. The serum level of sICAM-1 was also significantly different between low-and high-eggexcreting groups (P < 0.05) and between intestinal and hepatosplenic groups (P < 0.005).
RESULTS
Soluble ICAM-1 levels are elevated in schistosomiasis patients. The aim of this study was to evaluate the levels of soluble adhesion molecules in age-and sex-matched individuals with differences in disease intensity or pathology. In the study population, individuals with high egg excretion (which is associated with greater intensity of infection and disease susceptibility [4] ) were mostly young adolescents, while severe hepatosplenic disease typically manifests itself in older individuals with more established disease. Therefore, to compare these more severe forms with appropriate age-and sexmatched controls, it was necessary to create four patient groups (Table 1) . Sera from high-and low-egg-excreting individuals (Fig. 1A) and from hepatosplenic and intestinal patients (Fig. 1B) were measured for sICAM-1 levels. All patient groups had significantly elevated levels of sICAM-1 when compared with individuals who had never been infected with the disease (P < 0.001; mean ± standard error of the mean of controls = 227.5 ± 25.2 ng/ml). In addition, high-eggexcreting individuals had significantly higher levels of sICAM-1 than low-egg-excreting individuals (544.7 ± 29.8 ng/ml versus 454.4 ± 20.3 ng/ml; P < 0.05), and hepatosplenic patients had significantly higher levels of sICAM-1 than intestinal patients (513.9 ± 29.4 ng/ml versus 389.7 ± 15.8 ng/ml; P < 0.005). Thus, higher levels of sICAM-1 were present in the sera of patients with more-severe disease states. There were no correlations observed between sICAM-1 levels and infection with A. lumbricoides or T. trichiura (data not shown).
sE-selectin levels in schistosomiasis patients. As with sICAM-1, sE-selectin levels were tested in the sera of patients with various clinical forms of schistosomiasis (Fig. 2 ). There were significant differences between never-infected controls (mean ± standard error of the mean = 32.1 + 3.3 ng/ml) and high-egg-excreting (55.7 ± 4.6 ng/ml; P < 0.001), low-eggexcreting (50.7 ± 4.9 ng/ml; P = 0.02), and intestinal (53.2 ± FIG. 2 . sE-selectin levels in sera of schistosomiasis patients. Sera from groups of patients who were high-or low-egg-excreting (A) or had intestinal or hepatosplenic disease forms (B) were tested for levels of sE-selectin by a two-site ELISA. High-(P < 0.001) and low-(P = 0.02) egg-excreting and intestinal (P = 0.005) groups had significantly different serum sE-selectin levels than the never-infected controls. Intestinal group patients had significantly higher levels of sE-selectin in their sera than did hepatosplenic group patients (P = 0.005).
5.5 ng/ml; P = 0.005) patient groups. Levels of sE-selectin in the sera of hepatosplenic patients (35.4 ± 3.2 ng/ml) were not different from those of control patients. In contrast to the sICAM-1 data, high-egg-excreting and low-egg-excreting patient group sE-selectin levels did not differ from each other ( Fig. 2A) . Also, although the sE-selectin levels of intestinal and hepatosplenic patient groups were significantly different (P = 0.005), the intestinal group had the higher sE-selectin levels (Fig. 2B) , while the hepatosplenic group had the higher sICAM-1 levels (Fig. 1B) . Again, there were no correlations between sE-selectin levels and other parasitic infections (data not shown).
Relationship of sICAM-1 and sE-selectin levels. Because many of the cytokines which upregulate ICAM-1 expression also upregulate E-selectin expression (5, 6, 17, 37) , regression analyses comparing sICAM-1 and sE-selectin levels in patient sera were performed (Fig. 3) . Interestingly, there was a strong positive correlation of sICAM-1 and sE-selectin levels in the sera of high-and low-egg-excreting patient groups (r = 0.572, P = 0.0001) (Fig. 3A) , but no relationship was found between serum sICAM-1 and sE-selectin levels of intestinal and hepatosplenic patients (r = 0.078, P = 0.5514) (Fig. 3B ). This lack of correlation was attributable primarily to the effects of the hepatosplenic group. When the sICAM-1 and sE-selectin levels were compared for the intestinal patients alone, there was a significant correlation (r = 0.400, P = 0.035 [data not shown]).
TNF-a levels in patient sera. TNF-ox induces expression of both ICAM-1 and E-selectin (5, 6, 37), effects release of ICAM-1 and E-selectin from cells (2, 40), seems to be important for granuloma formation in schistosomiasis (1, 13, 27) , and has been shown to be elevated in the sera of schistosomiasis patients (58) . Therefore, the level of this cytokine was measured in patient sera to determine if it was associated with the elevated sICAM-1 and/or sE-selectin levels seen in the sera of these patients. Very few patients had appreciable levels of TNF-a in their sera (data not shown). 3 . Correlative analysis of sICAM-1 and sE-selectin serum levels. Simple regression analysis was performed to establish the correlation between serum sICAM-1 and sE-selectin levels in highand low-egg-excreting (A) and intestinal and hepatosplenic (B) patient groups. There was a significant correlation between serum sICAM-1 and sE-selectin levels in high-and low-egg-excreting groups (r = 0.572, P = 0.0001) but no correlation between serum sICAM-1 and sE-selectin in intestinal and hepatosplenic patient groups (r = 0.078, P = 0.5514).
or sE-selectin levels. Thus, serum concentrations of TNF-oL did not appear to correlate with clinical form, sICAM-1 levels, or sE-selectin levels in schistosomiasis. However, these measurements were made on serum samples from peripheral blood, and it has been suggested that peripheral blood TNF-a levels may not be a true reflection of portal blood or visceral tissue TNF-a bioactivity (1, 54) since TNF-a-producing cells may be sequestered from the circulation of schistosomiasis patients (58) .
Proliferative response to egg antigens negatively correlates with sICAM-1 level. High-and low-egg-excreting patient sICAM-1 levels were compared with PBMC proliferative responses to schistosome antigens, purified protein derivative, and the mitogen phytohemagglutinin. Hepatosplenic and intestinal patients were not included in the comparison as most hepatosplenic patients were antigen nonresponsive. A significant negative correlation existed between sICAM-1 levels and the proliferative response (E/C) to egg antigens (r = 0.367, P = 0.0023 [data not shown]). Standardized residual analysis indicated greater E/C variances at lower sICAM-1 levels than at higher sICAM-1 levels, signifying that the relationship between the proliferative response and the sICAM-1 level may be better described by a nonlinear equation. Natural logarithmic transformation of proliferative responses (ln E/C) maintained a significant negative correlation with sICAM-1 levels (Fig. 4) and improved the linearity of the regression curve (r = 0.408, P = 0.0006). Nonparametric Spearman rank coefficient analysis (which is not affected by the form of the equation) of the data also demonstrated that this relationship was significant (rho = -0.410, P = 0.0011). The relationship between sICAM-1 levels in sera and proliferative responses to SEA was also significant if the data were expressed as E -C (r = 0.259, P = 0.0389) or ln(E -C) (r = 0.385, P = 0.0017; by Spearman analysis, rho = -0.374, P = 0.003). The inverse relationship seen between sICAM-1 levels and the proliferative response was not due to variations in the control responses since control thymidine incorporation did not alter with changes in sICAM-1 levels (r = 0.01, P = 0.934 [data not shown]). Responses to other schistosome antigens, purified protein derivative, and phytohemagglutinin had no relationship to sICAM-1 levels (data not shown). Regression analyses comparing the relationship between sE-selectin levels and proliferative responses of high-and low-egg-excreting individuals were also performed. There were no significant correlations between sE-selectin levels and any PBMC stimulant used (data not shown). Therefore, the relationship between sICAM-1 level and PBMC response to SEA was the only significant relationship that existed between PBMC proliferation and serum adhesion molecule concentration.
DISCUSSION
This study demonstrates elevated levels of soluble intercellular adhesion molecules in the sera of schistosomiasis patients. Compared with never-infected control individuals, sICAM-1 levels are elevated significantly in sera from adult patients with hepatosplenic and intestinal forms of disease as well as younger patients (whose final disease form is not yet 
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2699 evident) excreting either high or low numbers of eggs in their feces. Also, patients with relatively more-severe disease (hepatosplenic and high-egg-excreting patients) have significantly higher levels of sICAM-1 in their sera than patients with milder disease forms (intestinal and low-egg-excreting patients). Most likely, elevated sICAM-1 levels are a result of the inflammatory responses leading to granuloma formation, with higher sICAM-1 levels in severe disease forms reflecting the more intense inflammation which may be occurring in these patients. Soluble ICAM-1 levels are similarly related to disease severity in patients with primary biliary cirrhosis (53) and Hodgkin's disease (41) .
Levels of sE-selectin are also significantly elevated in the sera of schistosomiasis patients with most forms of the disease compared with those of never-infected control individuals. In contrast to sICAM-1, however, sE-selectin is not significantly elevated in patients with hepatosplenic disease. In addition, the difference in serum sE-selectin levels between high-and low-egg-excreting individuals is not significant. Regression analysis indicates a significant correlation between sICAM-1 and sE-selectin levels in sera from intestinal and high-and low-egg-excreting individuals but not in sera from hepatosplenic patients. This suggests that, although ICAM-1 and E-selectin are upregulated by many of the same mechanisms (5, 6, 17, 37) (40) . In addition, both sICAM-1 and sE-selectin are released as single polypeptides and retain their ligand specificities (2, 40, 43) ; this would be unlikely if their release were caused by membrane fragmentation (40) .
A second potential explanation for the correlation between increased sICAM-1 levels and decreased proliferative responses would be that cytokines important for granuloma modulation (and decreased proliferation to egg antigens) concurrently induce cellular release of sICAM-1 and that no cause-and-effect relationship exists between sICAM-1 level and the proliferative response. In fact, IFN--y, which has been shown to trigger release of sICAM-1 from cultured cells (2, 40) , is correlated with granuloma modulation (32 If either or both of these mechanisms of reduced costimulation occur in the granuloma or draining lymph node microenvironment, they would potentially lead to inappropriate presentation of egg antigens (but not antigens outside the granuloma) and the observed reduction in T-cell responsiveness specific for egg antigens. Consequently, sICAM-1 released through the granuloma inflammatory response could provide a mechanism for feedback control of SEA-specific T-cell responsiveness, resulting in granuloma modulation. This theory remains highly speculative and circumstantial with the limited current data concerning intercellular adhesion molecules in schistosomiasis. However, with the recent demonstration of elevated ICAM-1 expression associated with acutely forming granulomas in murine schistosomiasis (42) and the data derived from this study, cell surface and soluble adhesion molecules may participate in regulating the pathology associated with schistosomiasis.
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